Bluedot Bio is an innovative biotechnology company bringing together an experienced team to develop breakthrough technology. Our mission is to produce effective treatments and therapies for prevalent and rare diseases by leveraging our extensive expertise in science, business, and biotechnology. To achieve our mission, Bluedot supports promising portfolio companies, as well as drives the development of BB1001, an internal drug development program. BB1001 is a first-in-class platform technology that inhibits key transcription factors critical to disease progression. To learn more about Bluedot Bio, our portfolio company, and BB1001, please contact us at www.bluedotbio.com.
Company Details
- Employees
- 6
- Founded
- 2021
- Address
- Great Neck, New York 11021, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bluedotbio.com
- Keywords
- Biotech, HNSCC, NSCLC, CRC, Early-stage development.
- HQ
- Great Neck, New York
Bluedot Bio Inc Questions
Bluedot Bio Inc's website is http://www.bluedotbio.com
Bluedot Bio Inc's LinkedIn profile is https://www.linkedin.com/company/bluedot-bio
Bluedot Bio Inc has
6 employees.
View email and phone details for 6
employees at Bluedot Bio Inc.
Bluedot Bio Inc's industry is
Biotechnology Research
Bluedot Bio Inc's top competitors are
Oncoheroes Biosciences,
Angelink,
Qral Ventures,
Tokyo Medical And Dental University,
Window Therapeutics, Inc.,
Aim-Hi Accelerator Fund,
Qral Group,
Vectgen Biosciences,
National Foundation For Cancer Research (Nfcr),
Qoolo.
Bluedot Bio Inc's categories are Biotechnology Research
Bluedot Bio Inc's founding year is 2021
